Fremanezumab and Non-High-Dose Galcanezumab for Comorbid Cluster Headache in Patients with Migraine: Three Cases

• Ngā kaituhi matua: Kenta Kashiwagi (Author), Masahito Katsuki (Author), Shin Kawamura (Author), Senju Tachikawa (Author), Atsuko Ono (Author), Akihito Koh (Author)
• Hōputu: Pukapuka
• I whakaputaina: MDPI AG, 2023-02-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

A new treatment option for cluster headache (CH) prevention is needed. Monoclonal antibodies (mABs) against calcitonin gene-related peptide (CGRP) ligands are used as a preventative treatment for migraine. Considering the CGRP's role in the CH attack's ignition and upkeep, fremanezumab and...